RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors
- PMID: 28040596
- DOI: 10.1016/j.biopha.2016.12.071
RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors
Retraction in
-
Retraction notice to "Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors" [Biomed. Pharmacother. 87 (2017) 37-45].Biomed Pharmacother. 2017 Dec;96:1570. doi: 10.1016/j.biopha.2017.07.062. Epub 2017 Jul 21. Biomed Pharmacother. 2017. PMID: 28739296 No abstract available.
Abstract
Myocardial infarction has been reported to be responsible for about 7.3 million deaths each year globally. Present treatments for myocardial infarction have been more palliative rather than curative. Over the past few years, stem cells have demonstrated its potency in regenerating damaged cardiac tissue, especially after myocardial infarction. However, limited short half-life of the protein and cell therapy and low transplanted cell survival rate as demonstrated via several clinical trials have lead to development of more potent and novel delivery systems like biomaterial delivery system and the use of various growth factors. In this review, we will be enumerating and discussing the recent advances in cardiac regeneration with focus on stem cell, biomaterial and growth factors.
Keywords: Biomaterials; Cell therapy; Delivery systems; Myocardial infarction; Protein therapy.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
